Large Increase in Poison Control Calls for Children Taking ADHD Drugs
New data shows that calls to US poison control centers have increased significantly for children taking stimulant ADHD drugs.
SSRI Exposure in Pregnancy Alters Fetal Neurodevelopment
Alterations in gray matter and white matter development found in infants of mothers taking SSRI antidepressants during pregnancy.
Suicides Are Increasing ā And So Are Antidepressant Prescriptions
Disturbingly, our study and others reveal that the black box warning is now ignored in many countries, since antidepressant prescriptions for children are on the rise again. Despite increasing certainty that antidepressants are ineffective and likely cause suicidal behavior in young people, psychiatry continues to claim that they reduce suicide risk.
Call to Monitor Adverse Effects of Antipsychotics in Youth
Researchers point to the risks of using antipsychotics with youth and caution against the practice.
Prescripticide: A Proposal for Action and a Request for Your Help
The primary factor protecting psychiatryās unwarranted power and authority is that it is perceived as shielding society from folks who are believed to be dangerous. It would seem, then, that one logical step toward reducing societyās trust in biological psychiatry would be to reveal the evidence of a significant correlation between theĀ use ofĀ prescribed psychoactive drugs and the commission of violent acts against oneself or others.
Study Shows Success With Reduced Antipsychotic Use
People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.
Valproate Linked to Decreased Brain Volume in Children Diagnosed with Bipolar Disorder
Researchers find that valproate decreases brain volume in a region associated with emotion processing across all participants.
Study Reduces Over-prescription of Antipsychotics in Older Adults
New intervention shows promise in reducing over-prescription of off-label antipsychotics in older adults.
Unsafe Use of Sleep Drug Zolpidem is Common
Three out of four users of the sedative, zolpidem (brand name Ambien), do not follow FDA recommendations to reduce risk.
New Research Suggests Brain Abnormalities in āSchizophreniaā May Result From Antipsychotics
Study finds that reduced cortical thickness and brain surface area associated with 'schizophrenia' may result from antipsychotic drug use.
FDA Defends Decision to Approve Digital Aripiprazole
Members of the U.S. Food and Drug Administrationās Psychiatry Products division go on the defensive in a new article, responding to concerns about the agencyās approval of digital aripiprazole.
Addressing Depression and Heart Disease with Exercise and Physical Activity
A new study examines the effects of midlife exercise on depression and cardiovascular health later in life.
Research Finds Parentsā Trauma May Impact Childrenās Health
Study uncovers some of the intergenerational consequences of adverse childhood experiences (ACEs).
Citizens Petition Calls for Sexual Side Effect Warnings
Researchers take action after study exposes enduring sexual dysfunction as a potential side effect of serotonin reuptake inhibiting antidepressants, 5Ī±-reductase inhibitors, and isotretinoin.
Despite the Evidence, Overprescription of Stimulants Continues
A new study finds that stimulant prescribing rates to children continue to rise despite the well-established evidence documenting overdiagnosis of ADHD and overprescription of stimulants.
Randomized Controlled Trials of Psychiatric Drugs Tell of Harm Done
The most important data in an RCT is not whether the drug provides a statistically significant benefit over placebo. The most important data is the ānumber needed to treatā calculation (NNT). ForĀ the personĀ considering taking an antidepressant or an antipsychotic, the NNT data providesĀ the āmathāĀ needed to weigh the potential benefit of taking the drug against the potential harm of doing so.
Rising Rates of Suicide: When Do We Acknowledge That Something Isn’t Working?!
Scapegoating a purported unseen "illness" may provide temporary comfort from acknowledging the horrors and injustice of the world, but it is a delusion ā and one with fatal consequences for many. When 45,000 people a year would rather die than live in this world any longer, it might behoove us all to consider what is happening in the world to cause this.
Review of Pediatric Antidepressant Studies Finds Evidence of Benefit Lacking
Review of pediatric antidepressant studies finds the vast majority are negative on primary outcomes and an increased risk for suicidality.
New Clinical Guidelines on Deprescribing Benzodiazepines
New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.
Review Finds Lack of Evidence for Antidepressants in Treatment of Insomnia
Results from a Cochrane meta-analysis find that the common practice of prescribing antidepressants to treat insomnia is not supported by current evidence.
More Evidence That Physical Activity Prevents Depression
Higher levels of physical activity serve as a protective factor for the future development of depression.
Neurofeedback is Not For Everyone: The Dangers of Neurology
One thing I noticed, from the moment that I stepped out of my psychiatristās office, was how strangely blank and yet clear my mind was. I felt surprisingly calm and relaxed, and I decided to go back for another treatment the next week. What I couldnāt have known then was that after that next ātreatment,ā life would be completely destroyed for me.
Intimate Partner Violence Doubles Risk for Postnatal Depression in Malaysian Women
Women in Malaysia exposed to intimate partner violence are twice as likely to experience postnatal depression.
Increasing Antidepressant Dose Does Not Improve Outcomes
A systematic review of literature and meta-analysis indicates that there is no clinically or statistically significant effect of antidepressant dose increase after nonresponse to initial treatment.
Rethinking Madness and Medication: Researcher Discusses Psychiatric Drug Withdrawal and Survivor Movements
New understandings of medication and withdrawal experiences warrant rethinking conceptualizations of health and āmadness."
